Toward postnatal reversal of ocular congenital malformations
- PMID: 24355915
- PMCID: PMC3871257
- DOI: 10.1172/JCI73560
Toward postnatal reversal of ocular congenital malformations
Abstract
Aniridia is a panocular disorder that severely affects vision in early life. Most cases are caused by dominantly inherited mutations or deletions of the PAX6 gene, which encodes a transcription factor that is essential for the development of the eye and the central nervous system. In this issue of the JCI, Gregory-Evans and colleagues demonstrate that early postnatal topical administration of an ataluren-based formulation reverses congenital malformations in the postnatal mouse eye, providing evidence that manipulation of PAX6 after birth may lead to corrective tissue remodeling. These findings offer hope that ataluren administration could be a therapeutic paradigm applicable to some major congenital eye defects.
Comment on
-
Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects.J Clin Invest. 2014 Jan;124(1):111-6. doi: 10.1172/JCI70462. Epub 2013 Dec 20. J Clin Invest. 2014. PMID: 24355924 Free PMC article.
References
-
- Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999;8(10):1893–1900. - PubMed
-
- Mort M, Ivanov D, Cooper DN, Chuzhanova NA. A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat. 2008;29(8):1037–1047. - PubMed
-
- Prosser J, van Heyningen V. PAX6 mutations reviewed. Hum Mutat. 1998;11(2):93–108. - PubMed
-
- Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development. 1991;113(4):1435–1449. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources